相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation
Tania Jain et al.
LEUKEMIA & LYMPHOMA (2019)
The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection
Hyunwook Kwon et al.
CLINICAL TRANSPLANTATION (2019)
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection
Lena Schiffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hypogammaglobulinemia and bacterial infections following pediatric post-transplant lymphoproliferative disorder in the rituximab era
Fang Kuan Chiou et al.
PEDIATRIC TRANSPLANTATION (2019)
Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients
Masaki Yamada et al.
PEDIATRIC TRANSPLANTATION (2018)
A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
Candice Roufosse et al.
TRANSPLANTATION (2018)
Donor-Specific Antibodies in Kidney Transplant Recipients
Rubin Zhang
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
Mieko Toyoda et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
B cells in transplantation
Esme I. Dijke et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study
Thomas Schachtner et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
B-cell regulation and its application to transplantation
Menna R. Clatworthy
TRANSPLANT INTERNATIONAL (2014)
Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment
Hideki Ishida et al.
TRANSPLANT INTERNATIONAL (2014)
Analysis of Predictive and Preventive Factors for De Novo DSA in Kidney Transplant Recipients
Toshihito Hirai et al.
TRANSPLANTATION (2014)
Subclinical Epstein-Barr Virus Viremia Among Adult Renal Transplant Recipients: Incidence and Consequences
J. Bamoulid et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Complete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three-Year Follow-Up
M. M. Sarwal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation
Jennifer M. DeVos et al.
KIDNEY INTERNATIONAL (2012)
(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation
Britta Hoecker et al.
TRANSPLANT INTERNATIONAL (2012)
Monitoring Infection with Epstein-Barr Virus among Seromismatch Adult Renal Transplant Recipients
S. I. Martin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Subclinical Viremia Increases Risk for Chronic Allograft Injury in Pediatric Renal Transplantation
Jodi M. Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients
Audrey H. Lau et al.
PEDIATRIC TRANSPLANTATION (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients
Michael Green et al.
PEDIATRIC TRANSPLANTATION (2009)
Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts
Nils Lachmann et al.
TRANSPLANTATION (2009)
Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children
M. A. Bingler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids
R. A. McDonald et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Rituximab and intravenous immune globulin for desensitization during renal transplantation
Ashley A. Vo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients
Mieko Toyoda et al.
PEDIATRIC TRANSPLANTATION (2008)
Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation
Li Li et al.
PEDIATRIC TRANSPLANTATION (2007)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation
B Gruhn et al.
BONE MARROW TRANSPLANTATION (2003)
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
JWJ van Esser et al.
BLOOD (2002)
Measurement of the B→J/ψK*(892) decay amplitudes -: art. no. 241801
B Aubert et al.
PHYSICAL REVIEW LETTERS (2001)
Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
VR Dharnidharka et al.
TRANSPLANTATION (2001)
分享论文
